Allscripts Healthcare Solutions
- Home ›
- US ›
- Healthcare
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. The last earnings update was 56 days ago. More info.
Add to Portfolio Compare Print
- Allscripts Healthcare Solutions has significant price volatility in the past 3 months.
MDRX Share Price and Events
7 Day Returns
1 Year Returns
MDRX Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Allscripts Healthcare Solutions (MDRX) | -1.4% | -9.1% | -22.6% | -23.4% | -32.1% | -39.5% |
| US Healthcare Services | -2.6% | -0.5% | 6.2% | 21.4% | 52.8% | 48.8% |
| US Market | 0.2% | 2.1% | 8.5% | 6.3% | 37.9% | 45.7% |
1 Year Return vs Industry and Market
- MDRX underperformed the Healthcare Services industry which returned 21.4% over the past year.
- MDRX underperformed the Market in United States of America which returned 6.3% over the past year.
MDRX Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Allscripts Healthcare Solutions
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Allscripts Healthcare Solutions.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 19 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 11.2% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Healthcare Services Unlevered Beta | Simply Wall St/ S&P Global | 1.21 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.213 (1 + (1- 21%) (42.68%)) |
1.417 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.42 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.417 * 5.96%) |
11.17% |
Discounted Cash Flow Calculation for NasdaqGS:MDRX using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Allscripts Healthcare Solutions is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 11.17%) |
|
|---|---|---|---|
| 2019 | 93.60 | Analyst x3 | 84.19 |
| 2020 | 89.92 | Analyst x5 | 72.75 |
| 2021 | 109.30 | Analyst x1 | 79.55 |
| 2022 | 140.50 | Analyst x1 | 91.98 |
| 2023 | 143.00 | Analyst x2 | 84.20 |
| 2024 | 145.94 | Est @ 2.05% | 77.30 |
| 2025 | 149.23 | Est @ 2.26% | 71.10 |
| 2026 | 152.81 | Est @ 2.4% | 65.49 |
| 2027 | 156.63 | Est @ 2.5% | 60.38 |
| 2028 | 160.65 | Est @ 2.57% | 55.70 |
| Present value of next 10 years cash flows | $742.64 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $160.65 × (1 + 2.73%) ÷ (11.17% – 2.73%) |
$1,954.68 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $1,954.68 ÷ (1 + 11.17%)10 |
$677.76 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $742.64 + $677.76 |
$1,420.40 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $1,420.40 / 166.13 |
$8.55 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $8.55 |
| Current discount | Discount to share price of
$9.44
= -1 x ($9.44 - $8.55) / $8.55 |
-10.4% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Allscripts Healthcare Solutions is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Allscripts Healthcare Solutions's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Allscripts Healthcare Solutions's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $0.10 |
| NasdaqGS:MDRX Share Price ** | NasdaqGS (2019-04-18) in USD | $9.44 |
| United States of America Healthcare Services Industry PE Ratio | Median Figure of 14 Publicly-Listed Healthcare Services Companies | 76.25x |
| United States of America Market PE Ratio | Median Figure of 3,081 Publicly-Listed Companies | 18.15x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Allscripts Healthcare Solutions.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NasdaqGS:MDRX Share Price ÷ EPS (both in USD) = 9.44 ÷ 0.10 |
96.64x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Allscripts Healthcare Solutions is overvalued based on earnings compared to the US Healthcare Services industry average.
- Allscripts Healthcare Solutions is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Allscripts Healthcare Solutions's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 96.64x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 19 Analysts |
-19.6%per year |
| United States of America Healthcare Services Industry PEG Ratio | Median Figure of 13 Publicly-Listed Healthcare Services Companies | 2.48x |
| United States of America Market PEG Ratio | Median Figure of 2,109 Publicly-Listed Companies | 1.57x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 96.64x ÷ -19.6% |
-4.93x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Allscripts Healthcare Solutions earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Allscripts Healthcare Solutions's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $9.06 |
| NasdaqGS:MDRX Share Price * | NasdaqGS (2019-04-18) in USD | $9.44 |
| United States of America Healthcare Services Industry PB Ratio | Median Figure of 34 Publicly-Listed Healthcare Services Companies | 4.18x |
| United States of America Market PB Ratio | Median Figure of 5,178 Publicly-Listed Companies | 1.91x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NasdaqGS:MDRX Share Price ÷ Book Value per Share (both in USD) = 9.44 ÷ 9.06 |
1.04x |
* Primary Listing of Allscripts Healthcare Solutions.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Allscripts Healthcare Solutions is good value based on assets compared to the US Healthcare Services industry average.
Value checks
We assess Allscripts Healthcare Solutions's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check) Allscripts Healthcare Solutions has a total score of 1/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
MDRX Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Allscripts Healthcare Solutions's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.
Growth vs Market Checks
- Allscripts Healthcare Solutions's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
- Allscripts Healthcare Solutions's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NasdaqGS:MDRX Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 19 Analysts | -19.6% |
| NasdaqGS:MDRX Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 19 Analysts | 4.5% |
| United States of America Healthcare Services Industry Earnings Growth Rate | Market Cap Weighted Average | 22.5% |
| United States of America Healthcare Services Industry Revenue Growth Rate | Market Cap Weighted Average | 11.5% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.3% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 19 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 2,238 | 253 | 20 | 2 |
| 2022-12-31 | 2,123 | 219 | 10 | 2 |
| 2021-12-31 | 1,991 | 192 | -3 | 5 |
| 2020-12-31 | 1,873 | 242 | -15 | 17 |
| 2019-12-31 | 1,801 | 234 | -29 | 19 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 1,750 | 68 | 17 |
| 2018-09-30 | 2,079 | 188 | -14 |
| 2018-06-30 | 2,006 | 237 | -6 |
| 2018-03-31 | 1,907 | 262 | -225 |
| 2017-12-31 | 1,498 | 279 | -183 |
| 2017-09-30 | 1,714 | 257 | -210 |
| 2017-06-30 | 1,657 | 246 | -191 |
| 2017-03-31 | 1,618 | 269 | -48 |
| 2016-12-31 | 1,386 | 269 | 31 |
| 2016-09-30 | 1,470 | 268 | -2 |
| 2016-06-30 | 1,432 | 255 | 3 |
| 2016-03-31 | 1,397 | 229 | 10 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 19 Analyst Estimates (S&P Global) | See Below |
All data from Allscripts Healthcare Solutions Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 0.14 | 0.14 | 0.14 | 1.00 |
| 2022-12-31 | 0.07 | 0.07 | 0.07 | 1.00 |
| 2021-12-31 | -0.02 | -0.02 | -0.02 | 1.00 |
| 2020-12-31 | 0.06 | 0.36 | -0.34 | 10.00 |
| 2019-12-31 | -0.17 | -0.07 | -0.32 | 6.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | 0.10 |
| 2018-09-30 | -0.08 |
| 2018-06-30 | -0.03 |
| 2018-03-31 | -1.25 |
| 2017-12-31 | -1.01 |
| 2017-09-30 | -1.16 |
| 2017-06-30 | -1.05 |
| 2017-03-31 | -0.26 |
| 2016-12-31 | 0.17 |
| 2016-09-30 | -0.01 |
| 2016-06-30 | 0.02 |
| 2016-03-31 | 0.05 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Allscripts Healthcare Solutions is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
Future performance checks
We assess Allscripts Healthcare Solutions's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
MDRX Past Performance
How has Allscripts Healthcare Solutions performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Allscripts Healthcare Solutions's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
- Allscripts Healthcare Solutions has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
- Allscripts Healthcare Solutions has become profitable in the last year making it difficult to compare the US Healthcare Services industry average.
Earnings and Revenue History
All data from Allscripts Healthcare Solutions Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 1,749.96 | 17.20 | 449.27 | 268.41 |
| 2018-09-30 | 2,079.12 | -13.63 | 564.90 | 293.54 |
| 2018-06-30 | 2,006.28 | -6.23 | 549.24 | 274.85 |
| 2018-03-31 | 1,906.79 | -225.44 | 512.80 | 240.96 |
| 2017-12-31 | 1,497.71 | -182.96 | 395.89 | 202.28 |
| 2017-09-30 | 1,714.44 | -209.59 | 451.27 | 194.58 |
| 2017-06-30 | 1,657.39 | -191.19 | 432.69 | 188.67 |
| 2017-03-31 | 1,617.82 | -47.68 | 415.46 | 190.10 |
| 2016-12-31 | 1,386.07 | 31.11 | 334.52 | 178.53 |
| 2016-09-30 | 1,470.11 | -2.01 | 380.09 | 186.07 |
| 2016-06-30 | 1,432.20 | 2.93 | 362.35 | 188.63 |
| 2016-03-31 | 1,397.40 | 9.91 | 347.30 | 185.10 |
| 2015-12-31 | 1,386.39 | -2.23 | 339.18 | 184.79 |
| 2015-09-30 | 1,381.65 | -20.73 | 320.36 | 180.33 |
| 2015-06-30 | 1,372.56 | -41.25 | 339.35 | 178.59 |
| 2015-03-31 | 1,372.14 | -55.80 | 345.26 | 187.24 |
| 2014-12-31 | 1,377.87 | -66.45 | 358.68 | 192.82 |
| 2014-09-30 | 1,387.95 | -84.89 | 379.72 | 197.85 |
| 2014-06-30 | 1,372.75 | -108.07 | 384.39 | 198.69 |
| 2014-03-31 | 1,366.28 | -113.18 | 391.91 | 197.50 |
| 2013-12-31 | 1,373.06 | -104.03 | 395.10 | 195.85 |
| 2013-09-30 | 1,373.05 | -107.73 | 383.38 | 199.28 |
| 2013-06-30 | 1,403.55 | -49.42 | 369.08 | 190.28 |
| 2013-03-31 | 1,428.68 | -18.56 | 368.19 | 176.70 |
| 2012-12-31 | 1,446.33 | -1.15 | 384.37 | 162.16 |
| 2012-09-30 | 1,483.56 | 49.15 | 333.76 | 143.47 |
| 2012-06-30 | 1,486.61 | 58.91 | 335.50 | 131.70 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Allscripts Healthcare Solutions has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Allscripts Healthcare Solutions used its assets less efficiently than the US Healthcare Services industry average last year based on Return on Assets.
- It is difficult to establish if Allscripts Healthcare Solutions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Past performance checks
We assess Allscripts Healthcare Solutions's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
MDRX Health
How is Allscripts Healthcare Solutions's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Allscripts Healthcare Solutions's finances.
The net worth of a company is the difference between its assets and liabilities.
- Allscripts Healthcare Solutions is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Allscripts Healthcare Solutions's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Allscripts Healthcare Solutions Company Filings, last reported 3 months ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 1,580.43 | 669.36 | 174.24 |
| 2018-09-30 | 1,584.66 | 1,828.08 | 111.78 |
| 2018-06-30 | 1,597.46 | 1,646.47 | 135.85 |
| 2018-03-31 | 1,553.80 | 1,729.35 | 135.00 |
| 2017-12-31 | 1,591.61 | 937.86 | 119.47 |
| 2017-09-30 | 1,567.08 | 1,416.48 | 104.30 |
| 2017-06-30 | 1,575.10 | 1,346.53 | 82.71 |
| 2017-03-31 | 1,587.62 | 1,327.94 | 104.39 |
| 2016-12-31 | 1,660.89 | 1,331.38 | 95.61 |
| 2016-09-30 | 1,747.91 | 1,233.12 | 77.25 |
| 2016-06-30 | 1,718.51 | 1,197.25 | 90.66 |
| 2016-03-31 | 1,389.27 | 599.82 | 100.12 |
| 2015-12-31 | 1,419.07 | 625.63 | 116.87 |
| 2015-09-30 | 1,395.58 | 655.04 | 91.40 |
| 2015-06-30 | 1,391.54 | 662.59 | 76.54 |
| 2015-03-31 | 1,278.09 | 572.69 | 88.48 |
| 2014-12-31 | 1,284.22 | 566.69 | 53.17 |
| 2014-09-30 | 1,282.83 | 587.25 | 37.35 |
| 2014-06-30 | 1,299.12 | 558.99 | 39.25 |
| 2014-03-31 | 1,307.62 | 549.19 | 41.58 |
| 2013-12-31 | 1,318.15 | 561.94 | 62.95 |
| 2013-09-30 | 1,331.03 | 544.85 | 60.79 |
| 2013-06-30 | 1,367.58 | 545.07 | 71.98 |
| 2013-03-31 | 1,334.29 | 552.15 | 92.23 |
| 2012-12-31 | 1,284.34 | 443.54 | 103.96 |
| 2012-09-30 | 1,299.12 | 461.67 | 93.67 |
| 2012-06-30 | 1,280.74 | 490.96 | 120.37 |
- Allscripts Healthcare Solutions's level of debt (42.4%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has been reduced over the past 5 years (42.6% vs 42.4% today).
- Debt is not well covered by operating cash flow (10.1%, less than 20% of total debt).
- Unable to confirm if the interest payments on Allscripts Healthcare Solutions's debt are well covered by earnings due to lack of past financial data.
Financial health checks
We assess Allscripts Healthcare Solutions's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Allscripts Healthcare Solutions has a total score of 3/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
MDRX Dividends
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Allscripts Healthcare Solutions
shares you are expected to receive
$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Allscripts Healthcare Solutions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Allscripts Healthcare Solutions's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 19 Analyst Estimates (S&P Global) | See Below |
| Global Healthcare Services Industry Average Dividend Yield | Market Cap Weighted Average of 15 Stocks | 1.3% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2009 Stocks | 2.4% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | ||
| 2022-12-31 | ||
| 2021-12-31 | 0.00 | 3.00 |
| 2020-12-31 | 0.00 | 4.00 |
| 2019-12-31 | 0.00 | 4.00 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Allscripts Healthcare Solutions has not reported any payouts.
- Unable to verify if Allscripts Healthcare Solutions's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Allscripts Healthcare Solutions's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Allscripts Healthcare Solutions afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Allscripts Healthcare Solutions has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
MDRX Management
CEO
| COMPENSATION | $7,801,251 |
| AGE | 60 |
| TENURE AS CEO | 6.3 years |
CEO Bio
Mr. Paul M. Black has been the Chief Executive Officer of Allscripts Healthcare Solutions, Inc. since December 19, 2012. Mr. Black serves as an Adjunct Professor of Businss at the University of Missouri – Kansas City. He served as the President of Allscripts Healthcare Solutions, Inc. from December 19, 2012 to October 2015. Mr. Black served as a Senior Advisor at New Mountain Capital, LLC. He served as an Operating Executive at Genstar Capital, LLC. He spent 13 years at Cerner Corporation, where Mr. Black served as the Chief Sales Officer, an Executive Vice President of United States Client Organization, from 2003 to August 31, 2007 and served as the Chief Operating Officer, from February 2005 to August 31, 2007, with responsibility for operations and sales, technologies, managed services and intellectual property organizations. He joined Cerner Corp. in March of 1994 as a Regional Vice President. Mr. Black served as Senior Vice President and the Chief Sales Officer, since June 1998 and Executive Vice President, since September 2000. He served a number of positions for 12 years at International Business Machines Corporation (IBM), from 1982 to 1994, including as a Sales and Professional Services Branch Executive. Mr. Black has been the Chairman of Aris Teleradiology LLC, since December 2011. He serves as Director of Saepio Technologies, Inc. and eResearch Technology, Inc. Mr. Black serves on the Board of Directors of Biotronic NeuroNetwork. Mr. Black has been a Director of Allscripts Healthcare Solutions, Inc. since May 16, 2012, Netsmart Technologies, Inc. since January 31, 2011. He serves as a Member of the Board of Directors of Truman Medical Center, Inc. since 2001, Inmar Holdings Inc., Saepio Technologies, Inc., and Connextions, Inc. He served as a Director of Haemonetics Corporation since January 26, 2011. Mr. Black served as a Member of Chief Executive Officer Advisory Board of Great Point Partners, LLC, since 2011. He served as the Chairman of Truman Medical Center, Inc. Mr. Black has an MBA with emphasis in Marketing and Industrial Relations from the University of Iowa and a B.S. from Iowa State University.
CEO Compensation
- Paul's compensation has increased in line with Allscripts Healthcare Solutions recently becoming profitable.
- Paul's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Allscripts Healthcare Solutions management team in years:
- The tenure for the Allscripts Healthcare Solutions management team is about average.
Management Team
Paul Black
CEO & Director
$8M
60
6.3 yrs
Rick Poulton
President
$5M
53
3.5 yrs
Dennis Olis
Chief Financial Officer
$3M
55
1.9 yrs
Brian Farley
Executive VP
$3M
48
1.7 yrs
Lisa Khorey
Executive VP & Chief Client Delivery Officer
$3M
51
2.4 yrs
Stephen Shulstein
Vice President of Investor Relations
0.8 yrs
Paul Lewis
Senior Vice President of Sales & Services and Acting General Manager
12.3 yrs
Steve Lalonde
Senior Vice President
David Chambers
Managing Director of Asia Pacific
5.5 yrs
Tim Quigley
Senior Vice President of Professional & Managed IT Services
Board of Directors Tenure
Average tenure and age of the Allscripts Healthcare Solutions board of directors in years:
- The tenure for the Allscripts Healthcare Solutions board of directors is about average.
Board of Directors
Michael Klayko
Chairman of the Board
$428K
63
5.1 yrs
Paul Black
CEO & Director
$8M
60
7.3 yrs
David Stevens
Director
$303K
64
7.3 yrs
Greg Garrison
Director
$305K
64
3.8 yrs
Jon Judge
Director
$294K
64
2.9 yrs
Yancey Spruill
Director
$273K
50
2.9 yrs
Dave Stevens
Director
$272K
55
2.9 yrs
Mara Aspinall
Director
$275K
56
1.9 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 17. Dec 18 | Buy | P. Garrison | Individual | 13. Dec 18 | 13. Dec 18 | 1,000 | $9.80 | $9,798 | ||
| 17. Dec 18 | Buy | Jonathan Judge | Individual | 14. Dec 18 | 14. Dec 18 | 9,622 | $10.38 | $99,841 | ||
| 17. Dec 18 | Buy | Mara Aspinall | Individual | 14. Dec 18 | 14. Dec 18 | 963 | $10.39 | $10,006 | ||
| 14. Dec 18 | Sell | Richard Poulton | Individual | 13. Dec 18 | 13. Dec 18 | -60,000 | $9.86 | $-589,233 | ||
| 13. Dec 18 | Buy | Paul Black | Individual | 12. Dec 18 | 12. Dec 18 | 24,765 | $10.10 | $250,027 | ||
| 13. Dec 18 | Buy | Yancey Spruill | Individual | 12. Dec 18 | 12. Dec 18 | 12,000 | $10.07 | $120,840 | ||
Management checks
We assess Allscripts Healthcare Solutions's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Allscripts Healthcare Solutions has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
MDRX News
Simply Wall St News
Should You Be Concerned About Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Historical Volatility?
(NASDAQ:MDRX), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility).
Simply Wall St - – Full articleWith A 0.8% Return On Equity, Is Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) A Quality Stock?
By way of learning-by-doing, we'll look at ROE to gain a better understanding of Allscripts Healthcare Solutions, Inc. … Over the last twelve months Allscripts Healthcare Solutions has recorded a ROE of 0.8%. … See our latest analysis for Allscripts Healthcare Solutions?
Simply Wall St - – Full articleIs There Now An Opportunity In Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?
Allscripts Healthcare Solutions, Inc. … (NASDAQ:MDRX), which is in the healthcare services business, and is based in United States,. … Today I will analyse the most recent data on Allscripts Healthcare Solutions’s outlook and valuation to see if the opportunity still exists
Simply Wall St - – Full articleThe Allscripts Healthcare Solutions Share Price Is Down 36% So Some Shareholders Are Getting Worried
Allscripts Healthcare Solutions isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). … Over five years, Allscripts Healthcare Solutions grew its revenue at 8.5% per year. … Shareholders have seen the share price fall at 8.4% per year, for five years: a poor performance.
Simply Wall St - – Full articleIs Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Worth US$11.86 Based On Intrinsic Value?
by projecting its future cash flows and then discounting them to today's value. … Discounted Cash Flows (DCF). … If you are reading this and its not January 2019 then I highly recommend you check out the latest calculation for Allscripts Healthcare Solutions by following the link below
Simply Wall St - – Full articleDoes Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) CEO Salary Reflect Performance?
In 2012 Paul Black was appointed CEO of Allscripts Healthcare Solutions, Inc. … How Does Paul Black's Compensation Compare With Similar Sized Companies. … has a market capitalization of US$1.7b, and pays its CEO total annual compensation worth US$7.7m.
Simply Wall St - – Full articleHave Insiders Been Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Shares This Year?
So shareholders might well want to know whether insiders have been buying or selling shares in Allscripts Healthcare Solutions, Inc. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … The Last 12 Months Of Insider Transactions At Allscripts Healthcare Solutions.
Simply Wall St - – Full articleWhat Kind Of Share Price Volatility Should You Expect For Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)?
Volatility is considered to be a measure of risk in modern finance theory. … Every stock in the market is exposed to this volatility, which is linked to the fact that stocks prices are correlated in an efficient market. … Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility).
Simply Wall St - – Full articleIs Now An Opportune Moment To Examine Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)?
Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), which is in the healthcare services business, and is based in United States,. … A question to answer is whether Allscripts Healthcare Solutions's current trading price of $9.76 reflective of the actual value of the? … Let’s take a look at Allscripts Healthcare Solutions’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change
Simply Wall St - – Full articleIs Allscripts Healthcare Solutions Inc's (NASDAQ:MDRX) Balance Sheet Strong Enough To Weather A Storm?
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) with a market-capitalization of US$2.39b, rarely draw their attention. … Remember this is a very top-level look that focuses exclusively on financial health, so I recommend a deeper analysis. … View our latest analysis for Allscripts Healthcare Solutions
Simply Wall St - – Full articleMDRX Company Info
Description
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company operates in two segments, Clinical and Financial Solutions and Population Health. The Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Population Health segment offers health management, and financial management and patient engagement solutions to hospitals, health systems, accountable care organizations, and other care facilities. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Details
| Name: | Allscripts Healthcare Solutions, Inc. |
| MDRX | |
| Exchange: | NasdaqGS |
| Founded: | 1986 |
| $1,568,301,561 | |
| 166,133,640 | |
| Website: | http://www.allscripts.com |
| Address: |
Allscripts Healthcare Solutions, Inc. 222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois, 60654, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NasdaqGS | MDRX | Common Shares | Nasdaq Global Select | US | USD | 14. Mar 2006 | |
| DB | AL21 | Common Shares | Deutsche Boerse AG | DE | EUR | 14. Mar 2006 |
Number of employees
Current staff
Industry
| Health Care Technology | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/19 23:31 |
| End of day share price update: | 2019/04/18 00:00 |
| Last estimates confirmation: | 2019/04/11 |
| Last earnings filing: | 2019/02/22 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
